Lexicon Pharmaceuticals (LXRX) Names Ajay Bansal Executive Vice President and CFO
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced the appointment of Ajay Bansal as executive vice president, corporate development and chief financial officer. Mr. Bansal has more than 20 years of experience in the biotechnology and pharmaceutical industry in corporate finance, corporate and business development, strategic planning, and commercial operations.
Prior to joining Lexicon, Mr. Bansal was chief financial officer and executive vice president of corporate and business development for Tercica, Inc., which was acquired by Ipsen in 2008.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease.
Prior to joining Lexicon, Mr. Bansal was chief financial officer and executive vice president of corporate and business development for Tercica, Inc., which was acquired by Ipsen in 2008.
Subscribe to EasyStockAlerts.com & Get real-time e-mail alerts when news hits your stocks!
Lexicon is a biopharmaceutical company focused on discovering and developing breakthrough treatments for human disease.
You May Also Be Interested In
- Fred's, Inc. (FRED) Named Steven R. Fitzpatrick to Board of Directors
- Martha Stewart Living Omnimedia (MSO) Names Martha Stewart as Non-Executive Chairman
- YRC Worldwide (YRCW) Appoints Scott Ware as President of Holland Subsidiary
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
